Nationwide, fewer people smoke than did a decade ago, but the proportion who smoke menthol-flavored cigarettes is on the rise.
Zentalis shakes up PhIII plans in ovarian cancer; Halozyme’s deal with Acumen; Korro’s $117M private placement
Zentalis Pharma shakes up plans for Phase III in ovarian cancer: Zentalis announced Monday that it is no longer planning to test its lead candidate,